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Abstract. We describe a quantitative method for the determination of ethylenediaminetetraacetic acid (EDTA) in human serum
by gas chromatography mass spectrometry (GC-MS), liquid chromatography electrospray ionisation tandem mass spectrome-
try (LC-ESI-MS/MS), and desorption ionisation on silicon mass spectrometry (DIOS-MS). In the initial stages of the analysis,
endogenous metabolites (1-palmitoyl-sn-glycero-3-phosphocholine and 1-stearoyl-sn-glycero-3-phosphocholine) were readily
observed in LC-ESI-MS and DIOS-MS however, direct analysis of the EDTA free acid had limited sensitivity. In order to
improve EDTA detection we employed a straightforward esterification derivatization. The most successful derivatization pro-
cedure converted EDTA to its methyl ester and, since 13C isotopes of these reagents are readily available, internal standards
could be easily generated for quantitative analysis. This approach provided a limit of detection of 0.5 and 0.1 µM for GC-MS
and LC-ESI-MS, and offers a viable method for the EDTA detection.
1. Introduction
Ethylenediaminetetraacetic acid (EDTA) is a metal chelating agent that has been used extensively
for blood preservation [7]. When mixed with blood, EDTA immediately chelates the available calcium
preventing the formation of fibrin thereby inhibiting coagulation [7]. The concentration of EDTA in pre-
served blood tubes varies according to volume but usually is in the concentration range of 3–7 mM [6].
This high concentration of EDTA is an advantage in its analyses in criminal cases when the origin of
blood evidence is under dispute.
However, there are many factors that inhibit the analysis of EDTA including its ubiquitous use in a
variety of industries. Since its commercialization in the 1950’s [17], EDTA has been widely utilized as a
food colouring preservative [3], a water softener in laundry detergents [3] and a metal chelating agent in
photography [14]. This has resulted in the need of both sensitive and accurate methods of analysis and
the careful use of controls.
While there have been numerous advances in the analysis of EDTA, focus of research has been placed
on EDTA identification in its free acid state. EDTA detection in its free state is inhibited by its distrib-
ution among chromatographic peaks that correspond to several different metal species to which it may
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chelate. One reasonable approach is to convert all available EDTA to a single compound is to add excess
of one metal that strongly complexes with EDTA. The effectiveness of this method is highly dependent
on pH and the type of metal ion used, typically iron (III) [2], copper (II) [4,13] and nickel [12]. Moreover,
due to its non-volatile nature and polarity, typical methods of analysis such as liquid chromatography
mass spectrometry have been used for EDTA detection [10]. One of the most significant advances in
EDTA detection was made using capillary electrophoresis mass spectrometry (CE/MS), Sheppard and
Henion achieved detection levels of 0.025 µM [10]. It should be noted however, that these authors used
an in-house adapted liquid junction interface not commonly available.
Another avenue of investigation in an attempt to optimise detection levels is utilising gas chromatog-
raphy (GC). In order for this method to be viable for EDTA analysis, the molecule must be relatively
volatile and thermally stable. To accomplish this, the carboxylic acid groups in EDTA can be converted
to its ester via its reaction with an acidified alcohol. Esterification has been reported earlier for military
applications [1] and water analysis [14], however, the detection levels reported for these methods were
not ideal for dried bloodstain analysis in forensics.
Based on the current approaches used for EDTA analysis, it is apparent that there is a need for the
development of an easily accessible method of detection that will enable more straightforward analysis
of EDTA. In this study, we describe a simple derivatization procedure that enhances EDTA detection and
assess its applicability to three mass spectrometry platforms including GC-MS, LC-ESI-MS/MS and
DIOS-MS. During the course of these studies, two ubiquitous endogenous metabolites were observed
which could act as biomarkers for blood as an alternative to DNA testing [5].
2. Experimental methods
2.1. Materials
Optima grade methanol, optima grade acetonitrile, optima grade hydrochloric acid, and 49% hydroflu-
oric acid were obtained from Fisher Scientific. [13C]-Methanol with purity of >95%, 1-butanol of 99.9%,
formic acid of 95%, Biotech grade 99.9% dichloromethane and EDTA (MW 292.24) of 99.995% pu-
rity and were purchased from Sigma Aldrich. EDTA was dissolved in nanopure water (pH 8, adjusted
with ammonium hydroxide (Fisher Scientific)) to obtain the stock solution (1000 µM). Serum (male
AB human serum, sterile filtered) used in the quantitative analysis was obtained from Sigma. Absolute
ethanol was purchased from AAPER alcohol and Chemical Company and pentafluorophenylpropy-
ldimethylchlorosilane used for surface modification was purchased from Gelest, Inc.
2.2. EDTA extraction from complex mixtures
Cold methanol (100 µl) was added to EDTA spiked serum samples (50 µl) and the mixture was mixed
by vortexing for 1 min. Samples were then placed for 20 min in a 4◦C block to aid protein precipitation
and then centrifuged at 13,400 × g for 10 min at 4◦C to pellet the protein. The supernatant was taken
and placed in a clean 2 ml glass vial and was used for derivatization.
2.3. Preparation of the methyl ester derivative and 13C methyl ester of EDTA
The methylation of EDTA was prepared by a simple derivatization procedure. Both the standard and
isolated EDTA samples were dried at 60◦C using a SpeedVac (Jouan RC1010) and reconstituted in 3 M
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hydrochloric acid in methanol (1 ml). The reaction mixture was incubated for 4 hours at 65◦C in a capped
2 ml glass vial followed by evaporation to dryness. The derivatized EDTA sample was reconstituted in
water and a series of working solutions were prepared. The [13C]-methyl ester analogue of EDTA was
used as an internal standard and was prepared using [13C]-methanol as the reagent for the derivatization
procedure.
2.4. Butylation of EDTA
EDTA standard (1000 µM) in water was dried and reconstituted in 1 ml of 3 M hydrochloric acid in
butanol. Derivatization was performed in the same manner as methylation.
2.5. DIOS surface preparation
The DIOS chip preparation has been published earlier [9,16]. Briefly, photopatterning of the silicon
wafer was achieved by etching low resistivity (0.005–0.02 Ω-cm) n-type Si (100) wafers in 25% v/v
hydrofluoric acid (HF)/ethanol through a 100 spot mask with white light illumination at a current density
of 5 mA/cm2 for 2 min. The hydride terminated chip was then washed with methanol and dried with a
stream of N2 before oxidation by a stream of ozone. Following the initial etching and oxidation, chips
were then re-etched in a 5% v/v HF/H2O solution and oxidised. DIOS chips were chemically modified
with pentafluorophenylpropyldimethylchlorosilane to generate silylated DIOS surface [15].
2.6. GC analysis of methyl ester EDTA standards
An Agilent Technologies 6890N gas chromatograph was used for the analysis. The analysis was
achieved with a methylsilicone (HP-MS5) column (30 m; 0.25 mm ID; 0.25 µM coating). The injec-
tor temperature was set at 290◦C and auxiliary temperature at 280◦C. The initial oven temperature was
at 50◦C for 4 min and then increased at 20◦C/min to 300◦C and held at 300◦C for 10 min. A splitless
injection was used, injecting 1 µl and acquisition delay was set for 4 minutes. Helium with a flow rate
of 0.8 ml/min was used as carrier gas. The selected ion monitoring (SIM) mode was also applied for low
concentration detection. Fragment peaks at m/z 174 and 176, for methylated EDTA and 13C methylated
EDTA respectively were used to generate the calibration curve.
2.7. Analysis of EDTA methyl ester by DIOS-MS
The DIOS chips were attached directly to a modified MALDI target plate with scotch tape and 0.5 µl
aliquots of sample were deposited on the porous surface and allowed to dry in air before DIOS analysis.
A Voyager DE-STR (Applied Biosystems) time-of-flight reflectron mass spectrometer with a pulsed
nitrogen laser operated at 337 nm was used for the DIOS experiments. A delayed extraction period of
10–100 ns was used to minimize the energy spread of the ions for optimum resolution. Mass spectra
were generated by averaging 100–150 individual laser shots into a single spectrum.
2.8. LC-MS and LC-MS/MS analyses
LC-MS analysis of underivatized and derivatized EDTA was performed on a Micromass Q-ToF micro
system equipped with a Z-spray electrospray source and a lockmass sprayer. The source temperature was
set to 110◦C with a cone gas flow of 50 l/h, a desolvation gas temperature of 365◦C and a nebulization gas
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flow of 350 l/h. The capillary voltage was set at 2.8 kV and the cone voltage at 25 V. The collision energy
was set at 16 V. LC separation was performed using a Waters 2795 HPLC separation module, together
with a C18 column (Symmetry R© Column, 2.1 × 100 mm, 3.5 µm particle size, Waters, Milford, MA).
Mobile phase A consisting of water/formic acid [100/0.1 (v/v)], and B consisting of acetonitrile/formic
acid [100/0.1 (v/v)] were used for positive ion analysis. The sample (5 µl) was applied to the column
and eluted at a flow rate of 250 µl/min under gradient conditions 5% B to 95% for 32 minutes. MS and
MS/MS data was collected for the mass range 100–1000 m/z. The analysis of the resulting total ion
chromatogram (TIC) was performed manually by generating extracted ion chromatograms (EICs) of the
expected ion.
2.9. Quantitative analysis
GC-MS calibration curve was constructed by plotting the peak area ratio of the analyte to the internal
standard versus the EDTA concentration. LC-MS calibration curve was obtained by plotting the peak
intensity ratio of m/z 174 to 176 versus concentration. All calibration curves were fitted to a non-
weighted linear regression. The precision of the method was measured as relative standard deviation
(RSD), which was obtained by calculating the percentage ratio of the standard deviation to the mean of
a minimum of three replicate measurements.
3. Results and discussion
Underivatized EDTA can be identified in preserved biological samples analysed by LC-MS at the
concentrations present in commercially available EDTA stoppered tubes (3–7 mM) [10,11]. However,
EDTA present in planted blood samples can be at significantly lower level and therefore there is a need
for a more sensitive method of analysis.
In our initial LC-MS investigations, we determined that EDTA in its free acid form was not detected
readily at low concentrations from EDTA spiked serum samples. To improve our detection, EDTA was
derivatized to its methyl and butyl ester forms (Scheme 1). Although the concept of derivatizing each
of the carboxylic acids is rather simple, derivatization must go to completion for this method to be
viable for quantitation. Derivatization parameters such as incubation times, temperature and reagent
were examined to determine optimal parameters. DIOS-MS was used as the mass analysis method for
these optimisation experiments, due to its high sensitivity and rapid sample analysis capabilities [8,15].
Incubation times of 1, 2, 3, 4, 6, and 18 hours, temperatures of 65 and 90◦C, and derivatization reagents
to facilitate the formation of the methyl and butyl esters were investigated. From these parameters it was
determined that complete methylation (tetramethyl ester) is achieved with 4 hour incubation at 65◦C
(Fig. 1). However, under the same conditions, butylation did not result in complete derivatization (Fig. 1)
possibly due to steric effects. To maximise butylation, an extended period of incubations were explored,
yet under extensive reactive conditions, butylation did not go to completion. Ultimately, because of
reduced incubation time for complete esterification, methylation was chosen for EDTA derivatization.
Scheme 1. Esterification reaction pathway of free acid EDTA, R=CH3 or CH2CH2CH2CH3.
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Figure 1. DIOS-MS of EDTA complete methylation at m/z 349 and DIOS-MS showing butylation not going to completion.
Complete derivatization to the butyl ester (m/z 517) was not observed.
It should also be noted that for both esterification reactions, higher temperatures were less favourable
because the EDTA ester became susceptible to water hydrolysis.
The simple methyl esterification reaction of EDTA allows for its analysis by GC-MS [14]. In addition,
the derivatization procedure enables the inclusion of a stable isotope analogue as internal standard for
quantitative analysis. Using [13C]-labelled methanol, the [13C]-EDTA internal standard can be readily
synthesized. GC-MS was the method of analysis originally developed for the studies as it allows for
the identification of molecules through retention time, formation of the molecular ion, and through the
fragmentation pattern. The mass spectrum of the ester derivative of EDTA (Fig. 2) shows the precursor
ion (M·+) at m/z 348 and an intense fragment at m/z 174 which corresponds to the loss of CH2N–
(CH2COOCH3)2. We also observed two prominent peaks at m/z 289 and 188 corresponding to the
loss of a methyl ester and an N–(CH2COOCH3)2 group, respectively. Based on the scanning mode
experiments on EDTA methyl ester standards, we obtained a detection limit (LOD) for the methyl ester
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Figure 2. GC-MS fragmentation pattern of methylated EDTA. (Inset) SIM TIC of fragment ion methylated EDTA (m/z 174)
and [13C]-analogue fragment ion (m/z 176).
derivative of 1000 µM. To improve the analytical sensitivity, selective ion monitoring mode (SIM) was
employed where a limit of detection of 0.5 µM was achieved. The prominent peaks at m/z 174 and
176 fragment ions of the methyl and [13C]-methyl esters of EDTA, respectively, were then used for the
quantitative analysis in serum. The SIM chromatograms in Fig. 2 (inset) depict a resolved baseline and
the two co-eluting compounds of methyl ester derivative of EDTA and its [13C] analogue.
The optimized esterification method described above was used to generate the calibration curve for
EDTA quantitative analysis in serum. Serum samples were spiked with EDTA at concentration of 0.5–
100 µM with a fixed amount of internal standard at 1.0 µM. The spiked serum samples were derivatized
and analysed in triplicate. The calibration curve was constructed by plotting the peak area ratio of m/z
174 and 176 versus the concentration. Figure 3a shows a linear response with a regression equation of
y = 0.34575x + 0.31242 and correlation coefficient of R = 0.99184 in the working concentration
range. The measured % RSD at a given concentration shown in Table 1 is 20% or lower indicating good
precision in the data. These results indicate the utility of the method in the detection of EDTA in complex
matrices.
The analysis was also developed on the LC-MS/MS platform to broaden the applicability of the deriva-
tization approach. Unlike GC-MS, EDTA in its free acid form can be detected using LC-MS, but only
at concentrations above 100 µM. Figure 4a shows the LC-MS TIC of serum spiked with 10 µM EDTA
and 1 µM [13C]-EDTA (internal standard) methyl ester derivatives. The mass spectrum of methylated
EDTA is characterized by an intense protonated peak at m/z 349 and a sodiated peak at m/z 371. The
protonated peak of the internal standard was observed at m/z 353 while the sodiated peak at m/z 375.
The fragmentation profile of the methyl ester derivative of EDTA (m/z 349) and of its [13C] analogue
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Figure 3. Plots of concentration vs. (a) peak area ratio using GC-MS and (b) peak intensity ratio using LC-MS of EDTA spiked
serum samples.
Table 1
Sample-to-sample reproducibility in the quantitative
analysis of EDTA in serum













(m/z 353) were generated using collision induced dissociation on an ESI-Q-ToF gave fragments at m/z
188 and 190, respectively corresponds to the loss of N–(CH2COOCH3)2 (Fig. 4b).
A calibration curve of EDTA methyl ester in serum was generated showing an limit of quantitation
(LOQ) of 0.1 µM. Serum samples were spiked with EDTA with concentration in the range of 0.01–
50 µM and a fixed amount of internal standard at 5 µM were derivatized and analysed in four replicates.
The calibration curve was constructed by plotting the MS/MS peak intensity of m/z 174 and 176 vs.
the concentration ratio. Figure 3b shows a linear response with a regression equation of y = 0.1712x +
0.0567 and correlation coefficient of R = 0.99714 in the working concentration range. The measured %
RSD at a given concentration shown in Table 1 is 20% or lower again indicating good precision in the
data.
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Figure 4. (a) LC-MS TIC of methylated EDTA spiked serum sample with 1 µM [13C]-methylated analogue as internal standard.
(b) LC-MS and tandem LC-MS mass spectra of the methylated and [13C]-methylated EDTA protonated ions at m/z 349 and
353, respectively.
A standard part of criminal investigations involving serum analysis is both EDTA analysis as well
as alternative testing methods to measure blood amount present. During the course of the LC-MS/MS
and DIOS-MS studies it should be noted that we readily observed numerous endogenous metabolites in
serum from the methanol extract (without derivatization). Among the most ubiquitous metabolites we
observed two phospholipids – 1-palmitoyl-sn-glycero-3-phosphocholine at m/z 496 and 1-stearoyl-sn-
glycero-3-phosphocholine at m/z 524 (Fig. 5). The MS/MS spectra of both metabolites and standards
helped confirm the identification of both metabolites.
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Figure 5. Metabolites identified in methanol extract, 1-palmitoyl-sn-glycero-3-phosphocholine (m/z 496) and 1-stearoyl-sn-
glycero-3-phosphocholine (m/z 524) using (a) LC-MS and (b) DIOS-MS.
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4. Conclusions
This study demonstrates the feasibility for performing a simple methyl ester derivatization of EDTA
from a complex mixture that enables enhanced detection from three different mass spectrometry plat-
forms. Quantitative analysis was also readily performed for EDTA detection from the serum samples.
The experiments also revealed the use of ubiquitous metabolites as potential biomarkers correlating with
the presence of serum.
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